Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell ...
J.Jill, Inc. (NYSE:JILL) ("J.Jill" or the "Company") today announced that it has successfully completed the refinancing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback